Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

NCT02143388 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Local Advanced High Risk Nasopharyngeal Carcinoma

Interventions

DRUG: IMRT combine with cisplatin concurrent chemotherapy
DRUG: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy

Sponsor

Zhao Chong

Collaborators

[object Object]
[object Object]
[object Object]